Medicare announced that therapeutic continuous glucose monitors that help to make treatment decisions will be considered durable medical equipment and covered, a move hailed by many.
Continuous glucose monitoring has not been around a long time, but it appears that some who use it, swear by it.
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
Sanofi and Dexcom are partnering with connected device startup Common Sensing in a clinical study to assess the performance of its insulin dosing technology.
More big news for Dexcom. Its G5 continuous glucose monitor will soon be available for use in several European countries.
Google X's life science division is being spun out as a brand new company, according to a restructuring announcement from Alphabet's Sergey Brin.
Google and DexCom are building a better glucose sensor; this will impact the Type 2 diabetes market and help usher in a new era of artificial pancreases.
Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.
DexCom has partnered with Google's life sciences arm to build a next-gen continuous glucose monitor. The new devices, expected out in the next 2-3 years, will be much smaller and cheaper, the companies say.
Rarely is the FDA accused of delivering a rapid assessment of a company’s technology. But that’s what happened last week when Dexcom’s mobile apps to free up users of its continuous glucose monitoring system got pre-market approval Friday afternoon. It was a move the company hadn’t expected for a couple more months and it scrambled […]
Dexcom marked a milestone Friday after it became the first company to get FDA pre-market approval for its mobile apps to support continuous glucose monitoring. It is part of a larger push to make it easier for care managers and loved ones to keep an eye on glucose levels to avoid complications, such as hyperglycemia, […]
Medtronic (MDT) made a big leap toward the future of healthcare in diabetes treatment innovations when it launched what media have hailed as the first artificial pancreas, the MiniMed 530G, earlier this fall. But it’s actually just an “artificial pancreas device system.” It’s not a true artificial pancreas. The MiniMed 530G is only Step 1, DexCom CEO Terry Gregg said. […]
Meevo offers an all-in-one solution for managing salon and spa employees. From scheduling and time tracking to payroll and promotions, Meevo streamlines operations and supports growth.